Amphastar Pharmaceuticals (AMPH) Land & Improvements (2013 - 2015)

Amphastar Pharmaceuticals' Land & Improvements history runs 3 years deep, the most recent figure standing at $6.9 million for Q2 2015.

• On a quarterly basis, Land & Improvements fell 3.62% year-over-year to $6.9 million in Q2 2015; TTM through Jun 2015 was $6.9 million, a 3.62% decrease from a year earlier, with the FY2014 full-year figure at $7.0 million, up 20.93% from the prior year.
• Land & Improvements held at $6.9 million in Q2 2015 per AMPH's latest filing, from $6.9 million in the prior quarter.
• Across five years, Land & Improvements topped out at $7.2 million in Q2 2014 and bottomed at $5.8 million in Q4 2013.
• The 3-year median for Land & Improvements is $7.0 million (2014), against an average of $6.8 million.
• Across the five-year window, Land & Improvements advanced 20.93% in 2014 and slipped 3.62% in 2015, its largest moves.
• Year by year, Land & Improvements stood at $5.8 million in 2013, then grew by 20.93% to $7.0 million in 2014, then declined by 1.51% to $6.9 million in 2015.
• Per Business Quant, the three latest AMPH Land & Improvements figures stand at $6.9 million (Q2 2015), $6.9 million (Q1 2015), and $7.0 million (Q4 2014).